|Number of Shares (mil)||254.15|
|Market Cap (mil)||63,614.34|
Getinge is built on a genuine compassion for people’s health, safety and well-being. Based on long experience and in close cooperation with the healthcare industry, Getinge develops innovative solutions that improve people’s lives, today and tomorrow – which is in line with the brand promise, Passion for life.
Getinge provides products and services for surgery, intensive-care, long-term care, infection control and sterilization. Founded in 1904 on the Swedish west coast, the company has grown to become a global market leader in many segments.
Today, Getinge generates sales of close to SEK 30 billion and conducts sales via proprietary companies throughout the world. The production is conducted at facilities in Brazil, Dominican Republic, France, Canada, China, Germany, Poland, Sweden, Turkey, the UK and the US.
In total, Getinge has over 15,500 employees in more than 40 countries. EMEA (Europe, Middle East and Africa) is the largest region with 42% of sales, closely followed by the Americas (North, South and Central America) with 40%, and APAC (Asia and Pacific) with 18%.
85% of sales are to hospitals, while elderly care accounts for 8% and the life science industry for 7%.
|Order intake, SEK M||26,817||30,431||30,142|
|Growth in order intake, adjusted for exchange-rate effects and acquisitions, %||0.7||1.9||-0.8|
|Net sales, SEK M||26,669||30,235||29,756|
|Net sales, adjusted for exchange-rate effects and acquisitions, %||0.6||1.8||-1.5|
|Restructuring and integration costs, SEK M||-1,162||-657||-1,313|
|Acquisition expenses, SEK M||-38||-33||-21|
|EBITA before restructuring, acquisition and integration costs, SEK M||4,501||4,179||4,341|
|EBITA margin before restructuring, acquisition and integration costs, %||16.9||13.8||14.6|
|Earnings per share after comprehensive tax, SEK||6.01||5.83||4.98|
|No. of shares, thousand||238,323||238,323||238,323|
|Interest-coverage ratio, multiple||5.70||4.6||5.6|
|Working capital, SEK M||36,529||40,771||43,383|
|Return on working capital, %||8.2||8.6||8.3|
|Return on shareholders’ equity, %||10.4||8.5||6.0|
|Net debt/equity ratio, multiple||1.21||1.17||1.12|
|Cash conversion, %||72.9||66.7||73.6|
|Equity/assets ratio, %||35.4||36.8||37.9|
|Equity per share, SEK||78.44||82.21||87.76|